(Q51309830)

English

Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients.

scientific article published on 5 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

hypereosinophilic syndrome

1 reference

based on heuristic

inferred from title

idiopathic hypereosinophilic syndrome

1 reference

based on heuristic

inferred from title

object named as

Tomasz Francuz

3

0 references

Grzegorz Helbig

1

object named as

Grzegorz Helbig

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

Slawomira Kyrcz-Krzemien

5

object named as

Sławomira Kyrcz-Krzemień

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

author name string

Katarzyna Wiśniewska-Piąty

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

Joanna Dziaczkowska-Suszek

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

publication date

5 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

54

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

807-811

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

Eosinophilia: secondary, clonal and idiopathic

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Advances in the immunobiology of eosinophils and their role in disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Heterogeneity among characteristics of hypereosinophilic syndromes.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Treatment of patients with the hypereosinophilic syndrome with mepolizumab

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Clinical overview of hypereosinophilic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation status

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.731602

21 January 2018

Identifiers

10.3109/10428194.2012.731602

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22988896

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51309830&oldid=1761869067"